My son has cancer. Kalshi wants you to be able to bet on his medical future | Joshua Pederson
Summary
A company called Kalshi plans to let people bet on the outcomes of medical drug trials and FDA approval decisions. This includes trials for serious illnesses like cancer and Alzheimer’s disease. The article shares a personal story about a boy with cancer and discusses concerns about the ethics of betting on life-saving treatments.Key Facts
- Kalshi is launching a pilot program where users can bet on results of drug trials and FDA decisions.
- The bets involve serious illnesses, including cancer and Alzheimer’s disease treatments.
- Kalshi’s CEO says the market helps share information about drug development that is usually hard to access.
- The author’s 12-year-old son has an aggressive tumor and is part of a cancer clinical trial.
- Clinical trials can be risky, with uncertain outcomes and difficult side effects.
- Some experts worry that betting on medical trials may harm research efforts.
- Kalshi currently does not allow bets on treatments involving children.
- The author finds the idea of betting against a child’s treatment upsetting and compares it to “death markets.”
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
